Skip to main content

Table 5 Projected direct costs by vaccination strategy for children <10 years old

From: Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model

 

Costs with PCV-7 vaccination, US$

Cost savings, US$*

PHiD-CV vs PCV-7

PCV-13 vs PCV-7

PHiD-CV vs PCV-13

Vaccine and vaccine administration cost

156,455,040

0

0

0

IPD cost

1,217,684

−112,966

−137,691

24,726

Pneumonia hospitalizations cost

3,939,050

−104,850

−117,264

12,413

AOM cost

98,833,034

−12,500,997

−3,228,848

−8,272,149

Total direct costs

260,444,808

−11,718,813

−3,483,803

−8,235,010

  1. *Negative numbers represent savings in favor of first comparator.
  2. AOM acute otitis media, IPD invasive pneumococcal disease, PCV-7 7-valent pneumococcal conjugate vaccine, PCV-13 13-valent pneumococcal conjugate vaccine, PHiD-CV pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine.